Article
DNA methylation‐based prognosis and epidrivers in hepatocellular carcinoma
2 Feb 2015
Abstract excerpt
UNLABELLED: Epigenetic deregulation has emerged as a driver in human malignancies. There is no clear understanding of the epigenetic alterations in hepatocellular carcinoma (HCC) and of the potential role of DNA methylation markers as prognostic biomarkers. Analysis of tumor tissue from 304 patients with HCC treated with surgical resection allowed us to generate a methylation-based prognostic signature using a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
